Chinese Journal of Dermatology ›› 2023, e0220147.doi: 10.35541/cjd.20220147
• Reviews • Previous Articles Next Articles
Jiang Jiayi, Wang Daguang
Received:
2022-03-07
Revised:
2023-07-12
Online:
2023-01-05
Published:
2023-11-21
Contact:
Wang Daguang
E-mail:wangirwin@126.com
Supported by:
Jiang Jiayi, Wang Daguang. Prevention and management of thrombus during the perioperative period after dermatologic surgery[J]. Chinese Journal of Dermatology,2023,e0220147. doi:10.35541/cjd.20220147
[1] | Parrish RH 2nd, Findley R, Elias KM, et al. Pharmacotherapeutic prophylaxis and post⁃operative outcomes within an Enhanced Recovery After Surgery(ERAS®) program: a randomized retrospective cohort study[J]. Ann Med Surg(Lond), 2022,73:103178. doi: 10.1016/j.amsu.2021.103178. |
[2] | Schmitt A, DePry J, Tsai S, et al. Retrospective evaluation of the safety of large skin flap, large skin graft, and interpolation flap surgery in the outpatient setting[J]. Dermatol Surg, 2018,44(12):1537⁃1546. doi: 10.1097/DSS.0000000000001605. |
[3] | Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence⁃Based Clinical Practice Guidelines[J]. Chest, 2012,141(2 Suppl):e227S⁃e277S. doi: 10.1378/chest.11⁃2297. |
[4] | Gajebasia S, Kerr R, Affleck A. Preoperative management of blood thinning agents during cutaneous surgery: the need for an individualized approach[J]. J Am Acad Dermatol, 2021,84(1):e41⁃e42. doi: 10.1016/j.jaad.2020.08.075. |
[5] | Redi U, Marruzzo G, Codolini L, et al. Venous thromboembolism prophylaxis in plastic surgery: state of the art and our approach[J]. Eur Rev Med Pharmacol Sci, 2021,25(21):6603⁃6612. doi: 10.26355/eurrev_202111_27103. |
[6] | Denzinger M, Held M, Amr A, et al. The influence of topically administered heparin on peripheral microcirculation of the skin: a double⁃blind, randomized, controlled preliminary study on 50 healthy subjects[J]. J Reconstr Microsurg, 2021,37(8):694⁃703. doi: 10.1055/s⁃0041⁃1726028. |
[7] | Taylor O, Carr C, Greif C, et al. Postoperative bleeding complications associated with blood thinning agents during Mohs micrographic surgery: a retrospective cohort study[J]. J Am Acad Dermatol, 2021,84(1):225⁃227. doi: 10.1016/j.jaad.2020. 06.011. |
[8] | Jørgensen L, Matzen RD, Albertsdottir E, et al. Complications in skin grafts when continuing antithrombotic therapy prior to cutaneous surgery requiring skin grafting: an observational study[J]. J Plast Surg Hand Surg, 2020,54(6):352⁃357. doi: 10.1080/2000656X.2020.1781141. |
[9] | Muzumdar S, Feng H. Application of cyanoacrylate to achieve hemostasis in elderly patients with inflamed, friable, and fragile skin receiving anticoagulation therapy after dermatologic surgery[J]. J Am Acad Dermatol, 2020,83(2):e97. doi: 10.1016/j.jaad. 2019.10.062. |
[10] | Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence⁃Based Clinical Practice Guidelines[J]. Chest, 2012,141(2 Suppl):e326S⁃e350S. doi: 10.1378/chest.11⁃2298. |
[11] | Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J, 2016,37(38):2893⁃2962. doi: 10.1093/eurheartj/ehw210. |
[12] | Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2021,143(5):e35⁃e71. doi: 10.1161/CIR.0000000000000932. |
[13] | Douketis JD, Foster GA, Crowther MA, et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy[J]. Arch Intern Med, 2000,160(22):3431⁃3436. doi: 10.1001/archinte.160.22.3431. |
[14] | Cabezas⁃Calderon V, Bassas Freixas P, García⁃Patos Briones V. Direct⁃acting oral anticoagulants in dermatologic surgery[J]. Actas Dermosifiliogr(Engl Ed), 2020,111(5):357⁃363. doi: 10.1016/j.ad.2019.10.002. |
[15] | Siscos SM, Neill BC, Singh AH, et al. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery[J]. J Am Acad Dermatol, 2021,84(2):425⁃431. doi: 10. 1016/j.jaad.2020.10.008. |
[16] | Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient⁃level network meta⁃analyses of randomized clinical trials with interaction testing by age and sex[J]. Circulation, 2022,145(4):242⁃255. doi: 10.1161/CIRCULATIONAHA.121.056355. |
[17] | Kubo K, Kato M, Mabe K, et al. Risk factors for delayed bleeding after therapeutic gastrointestinal endoscopy in patients receiving oral anticoagulants: a multicenter retrospective study[J]. Digestion, 2021,102(2):161⁃169. doi: 10.1159/000502952. |
[18] | Squizzato A, Poli D, Barcellona D, et al. Management of DOAC in patients undergoing planned surgery or invasive procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies(FCSA) position paper[J]. Thromb Haemost, 2022,122(3):329⁃335. doi: 10.1055/a⁃1715⁃5960. |
[19] | D′Anna L, Filippidis FT, Harvey K, et al. Ischemic stroke in oral anticoagulated patients with atrial fibrillation[J]. Acta Neurol Scand, 2022,145(3):288⁃296. doi: 10.1111/ane.13552. |
[20] | Ito T, Akamatsu K, Hasegawa H, et al. Relationship of warfarin versus DOACs with thrombogenic milieu in the left atrium among patients with nonvalvular atrial fibrillation[J]. Echocardiography, 2022,39(3):483⁃489. doi: 10.1111/echo.15319. |
[21] | Kishore K, Hariprasad SM, Mungee S. Perioperative antiplatelet agents and anticoagulants in vitreoretinal surgery[J]. Ophthalmic Surg Lasers Imaging Retina, 2022,53(2):71⁃78. doi: 10.3928/23258160⁃20220128⁃01. |
[22] | Goryo Y, Kume T, Okamoto H, et al. Influence of dual antiplatelet therapy duration on neointimal condition after second⁃generation drug⁃eluting stent implantation[J]. Cardiovasc Interv Ther, 2022,37(1):101⁃108. doi: 10.1007/s12928⁃021⁃00765⁃8. |
[23] | Harino T, Noura S, Hamabe A, et al. Impact of aspirin discontinuation on thrombotic complications in laparoscopic colorectal cancer surgery[J]. Surg Endosc, 2022,36(9):6432⁃6438. doi: 10.1007/s00464⁃021⁃08991⁃0. |
[24] | Xiang Y, Zhao H, Ding C, et al. The prophylactic use of tirofiban versus oral antiplatelet medications in stent⁃assisted coiling of intracranial aneurysms: a meta⁃analysis[J]. AJNR Am J Neuroradiol, 2021,42(4):713⁃719. doi: 10.3174/ajnr.A6996. |
[25] | Guo YZ, Zhao ZW, Li SM, et al. Clinical efficacy and safety of tirofiban combined with conventional dual antiplatelet therapy in ACS patients undergoing PCI[J]. Sci Rep, 2021,11(1):17144. doi: 10.1038/s41598⁃021⁃96606⁃y. |
[26] | Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents[J]. J Am Coll Cardiol, 2007,49(22):2145⁃2150. doi: 10.1016/j.jacc.2007.02.046. |
[1] | Hong Yongzhen, Wang Qian, Liang Junqin, . Application of next-generation sequencing in the field of non-hereditary dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220436-e20220436. |
[2] | Guo Lei, Cao Chunyan, Fang Xiaoya, Feng Suying. Analysis of current status and risk factors of multidrug-resistant bacteria wound infections in patients with autoimmune bullous diseases [J]. Chinese Journal of Dermatology, 2024, 57(2): 155-160. |
[3] | Sun Xiaojie, Liu Yi. Anti-androgen drugs in the treatment of skin diseases [J]. Chinese Journal of Dermatology, 2023, 56(9): 882-885. |
[4] | Jing Ke, Wang Yuan, Li Suo, Feng Suying. Autoimmune subepidermal bullous diseases characterized by annular erythema and blisters: a retrospective analysis of 25 cases [J]. Chinese Journal of Dermatology, 2023, 56(9): 832-838. |
[5] | Chen Yaolong, Liu Hui, Yao Zhirong, Gao Xinghua. Strategies and suggestions for improving the quality of guidelines and consensus in the field of dermatology [J]. Chinese Journal of Dermatology, 2023, 56(9): 805-808. |
[6] | Yang Xiaoli, Deng Danqi. Periodontitis and immune skin diseases [J]. Chinese Journal of Dermatology, 2023, 0(2): 20230059-e20230059. |
[7] | Liu Lihao, Hu Yu, Chen Kun. Clinical application and development of photobiomodulation in dermatology [J]. Chinese Journal of Dermatology, 2023, 0(2): 20230312-e20230312. |
[8] | Hao Feng, Liu Guoyan. Application of optical coherence tomography in dermatology [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220353-e20220353. |
[9] | Zhang Jiaqi, Wu Fan, Han Yuqing, Liu Qi, Pan Yao. Application of multi-photon microscopy in dermatology [J]. Chinese Journal of Dermatology, 2023, 0(2): 20230022-e20230022. |
[10] | Deng Wei, Zhang Gaolei, Chen Jianyou, Zhang Sheng, Jiang Lixiao, Liu Xiaoyan, Su Wei. Skin manifestations of 61 children with coronavirus disease 19 [J]. Chinese Journal of Dermatology, 2023, 56(12): 1154-1157. |
[11] | Zhu Xinyu, Pan Xiaoyuan, Yang Haijing, Wang Fei, Dong Zhengbang. Clinical features of coronavirus disease 2019 in patients with autoimmune blistering diseases [J]. Chinese Journal of Dermatology, 2023, 56(11): 1023-1027. |
[12] | You Ruixuan, Zeng Zhuotong, Qiu Xiangning, Xiao Rong. Biological agents targeting interleukin-23/Th17 axis in inflammatory skin diseases: from basic research to clinical application [J]. Chinese Journal of Dermatology, 2023, 56(11): 1065-1069. |
[13] | Wei Jin, Zang Dongjie, Zeng Sanwu, Jiang Jing, Lun Wenhui. Mutation analysis of the KRT5 gene in a Chinese pedigree with Dowling-Degos disease [J]. Chinese Journal of Dermatology, 2022, 55(8): 703-705. |
[14] | Jin Liang, Liu Ling. Treatment of some genodermatoses [J]. Chinese Journal of Dermatology, 2022, 55(8): 735-739. |
[15] | Xu Zhe. Some thoughts on hereditary dermatoses [J]. Chinese Journal of Dermatology, 2022, 55(8): 651-652. |
|